Browse by Clinical Topic:


Featured CME/CE Content:
 
neuroscienceCME Editors' Picks:



What's Next After Naloxone Rescue?

neuroscienceCME Webcast

Premiere Date: Friday, February 2, 2018

This activity offers CE credit for:

  1. Physicians (CME)
  2. Other


All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Creditâ„¢

Credit Expiration Date:
Saturday, February 2, 2019
Note: Credit Is No Longer Available

Faculty


Mark S. Gold, MDMark S. Gold, MD 
ASAM's Annual Lifetime Achievement John P. McGovern Award & Prize Winner
Adjunct Professor of Psychiatry
Washington University School of Medicine
St. Louis, MO
17th University of Florida Distinguished Alumni Professor
Gainesville, FL

Statement of Need

This video is a replay of a plenary session from the 10th Annual Chair Summit Master Class for Neuroscience Professional Development held in New Orleans, LA on November 16-18, 2017.
View this activity for 1 year for $5.00

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Review the impact of the expanding opioid crisis.
  • Match individuals with opioid use disorder with the appropriate evidence-based mediation assisted treatment (MAT) for their addiction.
  • Explore the linkage between drug overdoses.

Financial Support

This activity is supported by CME Outfitters, LLC.

Target Audience

Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other nonphysician healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters designates this enduring material for a maximum of .75 AMA RPA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/26340 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Gold reports that he is the chairman for the scientific advisory board for RiverMend Health.

Howard Bliwise, MD (peer reviewer) has no disclosures to report.

Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.

Daniela V. DiBiase, MS (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained fro the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

CHV-069-020218-00

Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download